Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sabrina Inselmann"'
Autor:
Christian Michel, Elisabeth K.M. Mack, Christopher-Nils Mais, Lea V. Fritz, Ying Wang, Lutz B. Jehn, Sonja K. Hühn, Clara Simon, Sabrina Inselmann, André Marquardt, Jennifer Kremer, Ellen Wollmer, Kristina Sohlbach, Andreas Neubauer, Cornelia A. Brendel, Claudia Haferlach, Gert Bange, Andreas Burchert
Publikováno v:
Haematologica, Vol 105, Iss 8 (2020)
Externí odkaz:
https://doaj.org/article/f0bd6271e0804c61a8997b643b08095e
Autor:
Sonja K. Hühn, Lutz B. Jehn, Gert Bange, Christian Michel, Ying Wang, André Marquardt, Clara Simon, Elisabeth Mack, Christopher-Nils Mais, Lea V. Fritz, Andreas Neubauer, Andreas Burchert, Ellen Wollmer, Jennifer Kremer, Kristina Sohlbach, Cornelia Brendel, Claudia Haferlach, Sabrina Inselmann
Publikováno v:
Haematologica
Autor:
Christoph Schliemann, Andreas Neubauer, Sabrina Inselmann, Bianca Altvater, We Berdel, Kristina Sohlbach, Andreas Burchert, M Lohoff, Tim Sauer, Wolfgang Hartmann, J R Knorrenschild, Jörn C. Albring, Sareetha Kailayangiri, M Stelljes, Christoph Groth, Claudia Rossig
Publikováno v:
Bone Marrow Transplantation. 52:317-320
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation
Autor:
E. Eigendorff, Christian Dietz, Cornelius F. Waller, G. Freunek, Martin C. Müller, Thomas Illmer, Mahon Fx, Andreas Neubauer, Florian Finkernagel, T H Brümmendorf, Joelle Guilhot, Stefan Hanzel, Rüdiger Hehlmann, Cornelia Brendel, Sabrina Inselmann, Magdalena Huber, S K Metzelder, Jolanta Dengler, Andreas Burchert, Yanfeng Wang, Susanne Saussele, Markus Pfirrmann, Thoralf Lange, Mariele Goebeler, Regina Herbst, Andreas Hochhaus, Christin Schütz
Publikováno v:
Leukemia. 32(4)
It is unknown, why only a minority of chronic myeloid leukemia (CML) patients sustains treatment free remission (TFR) after discontinuation of tyrosine kinase inhibitor (TKI) therapy in deep molecular remission (MR). Here we studied, whether expressi
Autor:
J Hoffmann, Sabrina Inselmann, Andreas Hochhaus, Philippe Kostrewa, Ruediger Hehlmann, Kristina Sohlbach, E. Eigendorff, Martin C. Müller, Andreas Neubauer, Andreas Burchert, J Ziermann, S K Metzelder, C. Schütz, Susanne Saussele
Publikováno v:
Leukemia. 29:1331-1335
A minority of chronic myeloid leukemia (CML) patients is capable of successfully discontinuing imatinib. Treatment modalities to increase this proportion are currently unknown. Here, we assessed the role of interferon alpha 2a (IFN) on therapy discon
Autor:
Thorsten Stiewe, Andreas Neubauer, S Gattenlöhner, S K Metzelder, Kristina Sohlbach, Martin Bornhäuser, Sabrina Inselmann, Andreas Burchert, Elisabeth Hessmann, Joël P. Charles, M Solovey, Christian Michel, Ying Wang, M von Bonin, M Rehberger, A Ten Haaf, Volker Ellenrieder, Cornelia Brendel
Publikováno v:
Leukemia. 29(7)
Internal tandem duplications (ITD) in the Fms-related tyrosine kinase 3 receptor (FLT3) are associated with a dismal prognosis in acute myeloid leukemia (AML). FLT3 inhibitors such as sorafenib may improve outcome, but only few patients display long-
Autor:
Pål Jarle Johnsen, Anthony M. Poole, Eske Willerslev, Søren Brunak, Wilfried Wackernagel, Kaare Magne Nielsen, J. Victor Moreno Mayar, Rasmus Nielsen, Klaus Harms, Ludovic Orlando, Oliver G. Pybus, Thomas Sicheritz-Pontén, Tais W. Dahl, Simon Rasmussen, Sabrina Inselmann, Johann de Vries, Søren Overballe-Petersen, Minik T. Rosing
DNA molecules are continuously released through decomposition of organic matter and are ubiquitous in most environments. Such DNA becomes fragmented and damaged (often100 bp) and may persist in the environment for more than half a million years. Frag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9449c4a8c2a38c19fa4aa1d305adb2
https://europepmc.org/articles/PMC3856829/
https://europepmc.org/articles/PMC3856829/
Autor:
Jolanta Dengler, Martin C. Müller, Susanne Saussele, Thoralf Lange, Stefan Hanzel, Andreas Neubauer, Thomas Illmer, Cornelia Brendel, Sabrina Inselmann, Andreas Hochhaus, Ying Wang, Christin Schütz, Ekkehard Eigendorff, Maria Elisabeth Goebeler, Regina Herbst, Tim H. Brümmendorf, Finkernagel Florian, Christian Dietz, Cornelius F. Waller, François Xavier Mahon, Gernot Freunek, Joelle Guilhot, Andreas Burchert
Publikováno v:
Blood. 126:599-599
Background Chronic myeloid leukemia (CML) stem cells are inherently insensitive to tyrosine-kinase inhibitors (TKI). However, an important minority of CML patients was shown to discontinue TKI without experiencing molecular relapse. Underlying mechan
Autor:
Cornelia Brendel, Andreas Neubauer, Sabrina Inselmann, Simone Liebler, Steffen Koschmieder, Andreas Burchert
Publikováno v:
Blood. 120:36-36
Abstract 36 Introduction: Chronic myeloid leukemia (CML) is caused by the BCR-ABL oncogene. CML patients lack expression of IRF-8 - an interferon-regulated transcription factor that has been shown to exert tumor suppressor functions. IRF-8 is also cr